Who Paid My Doc
Christopher Dy
Surgery of the Hand Saint Louis, MO Medical Doctor
NPI 1477712933 CMS profile 832138
4921 Parkview Pl, Dept Orthopaedic Surgery, Ste 6A/6B/12A, Saint Louis, MO 63110
General payments
$105,659
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$28,200
Through program year 2025, Christopher Dy of Saint Louis, MO is reported in the CMS Open Payments database as having received $105,659 across 82 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $28,200 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 97th percentile of Surgery of the Hand profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $25,946 | 12 | |
| 2024 | General | $33,808 | 29 | |
| 2023 | General | $31,629 | 15 | |
| 2022 | General | $956 | 5 | |
| 2021 | General | $2,584 | 11 | |
| 2020 | General | $1,857 | 4 | |
| 2019 | General | $8,879 | 6 |
Beside peers
- Christopher Dy
- Surgery of the Hand median
- Middle half of Surgery of the Hand
- National median
In program year 2025, general payments to Christopher Dy were reported at $25,946. Among 286 Surgery of the Hand profiles paid that year, the median was $288 and the middle half received between $115 and $1,242.
Show as a table
| Year | Christopher Dy | Surgery of the Hand median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $8,879 | $369 | $108–$1,516 | $163 |
| 2020 | $1,857 | $153 | $56–$898 | $114 |
| 2021 | $2,584 | $261 | $84–$1,296 | $132 |
| 2022 | $956 | $313 | $103–$1,562 | $149 |
| 2023 | $31,629 | $241 | $95–$876 | $160 |
| 2024 | $33,808 | $236 | $84–$890 | $164 |
| 2025 | $25,946 | $288 | $115–$1,242 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 6 drugsPart D claims
376
Drug cost
$1,773
Branded share of claims
49.2%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Gabapentin | Generic | 27 | $595 | |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | Brand | 63 | $373 | |
| Meloxicam | Generic | 164 | $342 | |
| Acetaminophen-Codeine Acetaminophen With Codeine | Brand | 73 | $220 | |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | Brand | 36 | $200 | |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | Brand | 13 | $43 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,399 Part D prescribers listed as Hand Surgery; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 67 billing codesPaid by Medicare
$94,049
Medicare patients
340
Services billed
7,271
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 71% | |
| Diabetes | 29% | |
| Depression | 26% | |
| Ischemic heart disease | 24% | |
| Chronic kidney disease | 21% | |
| Cancer | 17% | |
| Atrial fibrillation | 16% |
| Drug given in the clinic | Where | Patients | Services | Paid by Medicare |
|---|---|---|---|---|
| Injection, methylprednisolone acetate, 1 mg J1010 | Office | 89 | 6,400 | $633 |
| Injection, methylprednisolone acetate, 40 mg J1030 | Office | 35 | 53 | $206 |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
82 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Surgery of the Hand in Missouri
Jason Strelzow
Surgery of the Hand · Saint Louis, MO
Charles Goldfarb
Surgery of the Hand · Saint Louis, MO
Julia Nuelle
Surgery of the Hand · Columbia, MO
David Brogan
Surgery of the Hand · Saint Louis, MO
Sarah Ridenour
Surgery of the Hand · Saint Louis, MO
Marie Morris
Surgery of the Hand · Saint Louis, MO
Related records
Surgery of the Hand in Missouri
Practitioners in the same specialty and state, ranked by reported value.
All Surgery of the Hand
Everyone recorded under this specialty, nationwide.
Doctors in Missouri
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.